Diebold, Inc. (DBD) Tops Q4 EPS Views; Guides FY12 EPS Above Expectations
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $82.69 -0.23%
EPS Growth %: +30.9%
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +30.9%
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q4 EPS of $1.40, $0.56 better than the analyst estimate of $0.84. Revenue for the quarter came in at $850 million versus the consensus estimate of $839.85 million.
Diebold, Inc. sees FY2012 EPS of $2.30-$2.50, versus the consensus of $2.26.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Diebold, Inc. sees FY2012 EPS of $2.30-$2.50, versus the consensus of $2.26.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- MiniLuxe Expands Dallas Presence with Grand Opening of New Lakewood Studio
- Columbia Financial, Inc. Announces Preliminary Subscription Offering Results and Increase in Maximum Purchase Limits
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
